Alzheimer’s and Blood Glucose Levels Study 

The Alzheimer’s and Blood Glucose Levels Study is researching the differences in blood glucose levels between people with and without Mild Cognitive Impairment or Alzheimer’s disease, with the aim of early detection of Alzheimer’s disease.

 

 This study will collect continuous glucose monitor (CGM) data from participants already using CGMs to better understand the relationship between Alzheimer’s disease and blood glucose levels. This study will use the Endobits Companion app for data collection. The Endobits Companion app is freely available for Android and iOS mobile devices, and was designed to share their data for the study.   

About the Study:

This study will collect continuous glucose monitor (CGM) data from participants already using CGMs to better understand the relationship between Alzheimer’s Disease and blood glucose levels. This study will use the “Endobits Companion” app for data collection. The Endobits Companion app is freely available for Android and iOS mobile devices, and was designed to keep track of patients diabetes management through a journal and relay this information with their CGM readings to their caring physician.

Due to the current COVID-19 pandemic, this study is fully online.

The study is listed on the Alzheimer’s Prevention Registry, and you can learn more about it here. 

The information sheet for the study is available here.

You may be eligible for the Alzheimer’s and Blood Glucose Levels Study if you meet the following criteria:

  • Are ≥ 50 years old, and

  • Currently, use a continuous glucose monitor, and will continue to use it for the next 90 days

To enroll in the study, download the Endobits Companion app using the links below to get started. 

What is Involved:

This study involves using the “Endobits Companion” app, which is available from the Google Play and Apple App stores as a free download. Once signed up for the app, you will be asked to connect your continuous glucose monitor to the app and to fill out some basic information on yourself.  After this is complete, you can let the app run in the background and only have to use it as you like. The app will continue to collect data from your continuous glucose monitor over the study period of 90 days. After the study, you are free to continue using the app if you like. 

Diabit_Image_Features_-06.png
Diabit_Image_Features_-07.png
Diabit_Image_Features_-07.png
Diabit_Image_Features_-06.png